Cargando…
Rosiglitazone alleviates lipopolysaccharide-induced inflammation in RAW264.7 cells via inhibition of NF-κB and in a PPARγ-dependent manner
Rosiglitazone is a synthetic peroxisome proliferator-activated receptor (PPAR)γ agonist widely used for the treatment of type 2 diabetes. Recent studies have demonstrated that rosiglitazone displays anti-inflammatory effects. The present study aimed to investigate whether rosiglitazone alleviates de...
Autores principales: | Zhou, Jing-Ping, Yang, Xiao-Ning, Song, Yang, Zhou, Fei, Liu, Jing-Jing, Hu, Yi-Qun, Chen, Li-Gang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8138265/ https://www.ncbi.nlm.nih.gov/pubmed/34055059 http://dx.doi.org/10.3892/etm.2021.10175 |
Ejemplares similares
-
Anti-inflammatory Mechanism of Action of Benzoylmesaconine in Lipopolysaccharide-Stimulated RAW264.7 Cells
por: Zhou, Changkai, et al.
Publicado: (2022) -
Vaccaria hypaphorine alleviates lipopolysaccharide-induced inflammation via inactivation of NFκB and ERK pathways in Raw 264.7 cells
por: Sun, Haijian, et al.
Publicado: (2017) -
Cimifugin Inhibits Inflammatory Responses of RAW264.7 Cells Induced by Lipopolysaccharide
por: Han, Bin, et al.
Publicado: (2019) -
Coixol Suppresses NF-κB, MAPK Pathways and NLRP3 Inflammasome Activation in Lipopolysaccharide-Induced RAW 264.7 Cells
por: Hu, Yusheng, et al.
Publicado: (2020) -
The Anti-Inflammatory Mechanism of Flaxseed Linusorbs on Lipopolysaccharide-Induced RAW 264.7 Macrophages by Modulating TLR4/NF-κB/MAPK Pathway
por: Li, Jialong, et al.
Publicado: (2023)